UP!
| 2016-07-01 | Initiated Coverage | Roth Capital | Buy to Buy | |
| 2016-05-09 | Reiterated Rating | Brean Capital | Buy | $13.00 to $7.00 |
| 2016-05-08 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-08 | Reiterated Rating | FBR & Co | Buy | |
| 2016-04-18 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-03-15 | Reiterated Rating | FBR & Co. | Outperform | $16.00 |
| 2016-03-10 | Reiterated Rating | Brean Capital | Buy | $13.00 |
| 2016-02-04 | Reiterated Rating | Brean Capital | Buy | $13.00 |
| 2016-01-07 | Reiterated Rating | Roth Capital | Buy | $15.00 |
| 2016-01-07 | Reiterated Rating | Brean Capital | Buy | $13.00 |
| 2015-11-17 | Lower Price Target | JMP Securities | Market Outperform | $10.00 to $6.00 |
| 2015-11-05 | Lower Price Target | Stifel Nicolaus | Buy | $11.00 to $9.00 |
| 2015-10-30 | Reiterated Rating | FBR & Co. | Outperform | |
| 2015-09-25 | Reiterated Rating | JMP Securities | Outperform | $14.00 |
| 2015-09-25 | Reiterated Rating | Brean Capital | Buy | $13.00 |
| 2015-09-24 | Reiterated Rating | Piper Jaffray | Hold | $5.00 |
| 2015-09-24 | Reiterated Rating | Roth Capital | Buy | $15.00 |
| 2015-09-24 | Reiterated Rating | Piper Jaffray Cos. | Hold | $5.00 |
| 2015-09-22 | Initiated Coverage | HC Wainwright | Buy | $15.00 |
| 2015-09-22 | Initiated Coverage | HC Wainright | Buy | |
| 2015-07-01 | Reiterated Rating | Brean Capital | Buy | $13.00 |
| 2015-06-12 | Reiterated Rating | Brean Capital | Buy | $13.00 |
| 2015-04-27 | Initiated Coverage | Brean Capital | Buy | $13.00 |
| 2015-03-17 | Initiated Coverage | Roth Capital | Buy | $15.00 |
| 2015-03-12 | Lower Price Target | Stifel Nicolaus | Buy | $13.00 to $11.00 |
| 2015-03-06 | Set Price Target | MLV & Co. | Buy | $16.00 |
| 2015-01-09 | Lower Price Target | Roth Capital | Buy | $19.00 to $12.00 |
| 2015-01-09 | Downgrade | Piper Jaffray | Overweight to Neutral | |
| 2015-01-06 | Set Price Target | MLV & Co. | Buy | $16.00 |
| 2014-10-21 | Initiated Coverage | MLV & Co. | Buy | $16.00 |
| 2014-08-14 | Reiterated | Stifel | Buy | $14 to $13 |
| 2014-08-14 | Lower Price Target | Stifel Nicolaus | Buy | $14.00 to $13.00 |
| 2014-06-13 | Initiated Coverage | Roth Capital | Buy | $19.00 |
| 2014-03-28 | Lower Price Target | Stifel Nicolaus | $16.00 to $14.00 | |
| 2014-03-07 | Initiated Coverage | Roth Capital | Buy | |
| 2013-11-15 | Reiterated Rating | Stifel Nicolaus | Buy | $16.00 to $13.00 |
| 2016-07-01 | Initiated Coverage | Roth Capital | Buy to Buy | |
| 2016-05-09 | Reiterated Rating | Brean Capital | Buy | $13.00 to $7.00 |
| 2016-05-08 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-08 | Reiterated Rating | FBR & Co | Buy | |
| 2016-04-18 | Reiterated Rating | FBR & Co. | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CNAT 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| ADVENT VENTURE PARTNERS LLP | 13.83% (2166836) | CNAT / |
| Malik Shahzad | 13.83% (2166836) | AGEN / CNAT / VSAR / |
| COOPERATIVE GILDE HEALTHCARE II U.A. | 9.50% (1487320) | CNAT / |
| Perret Marc Olivier | 9.50% (1487320) | CNAT / |
| Scopa James Paul | 7.61% (1192080) | CNAT / |
| MPM BioVentures IV QP LP | 7.61% (1192080) | CNAT / EPZM / |
| EVNIN LUKE | 7.61% (1192080) | CNAT / EPRS / EPZM / ETRM / KBIO / PCRX / PIP / RDUS / |
| LACASSE LOUIS P | 5.17% (809887) | CNAT / TGEN / |
| Cashion Charles SVP, Finance, CFO and Sec. | 0.27% (42424) | CNAT / NBY / |
| Mento Steven J President, CEO & Director | 0.23% (36363) | CNAT / SGMO / |
| RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt | 0.19% (29280) | CNAT / |
| HALE DAVID F | 0.15% (24242) | CNAT / |
| Spada Alfred P. SVP, R&D and CSO | 0.08% (12121) | CNAT / |
| KLINGENSTEIN PAUL H | 0.06% (8731) | ANAC / CLVS / CNAT / ETRM / |
| Smith Edward F III SVP, Reg Affairs and QA | 0.03% (4461) | CNAT / |
| KISNER DANIEL L | 0.02% (3145) | CNAT / DVAX / LPTN / TKMR / |
UM